Published in
Mary Ann Liebert, Antioxidants and Redox Signaling, 14(23), p. 1113-1129, 2015
Links
- ORCID
- Mary Ann Liebert
- [archive-ouverte.unige.ch] | PDF
- [archive-ouverte.unige.ch] | PDF
- [digital.csic.es] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net]
- [www.ncbi.nlm.nih.gov] | PDF
- [sro.sussex.ac.uk] | PDF
Tools
Pharmacology and Clinical Drug Candidates in Redox Medicine
Journal article published in 2015 by
V. Thao-Vi Dao,
V. Thao Vi Dao,
Ana I. Casas,
Gus Maghzal,
Tamara Seredenina,
Nina Kaludercic,
Natalia Robledinos,
Fabio Di Lisa,
Roland Stocker,
Pietro Ghezzi 
,
Vincent Jaquet,
Antonio Cuadrado,
Harald Hhw H. W. Schmidt
,
Vincent Jaquet,
Antonio Cuadrado,
Harald Hhw H. W. Schmidt
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Oxidative stress is suggested to be a disease mechanism common to a wide range of disorders affecting human health. However, so far, the pharmacotherapeutic exploitation of this, for example, based on chemical scavenging of pro-oxidant molecules, has been unsuccessful.